Free Trial

Health In Tech (HIT) Competitors

Health In Tech logo
$0.66 -0.02 (-3.01%)
As of 02:31 PM Eastern

HIT vs. RDZN, ICCH, NEUE, ZBAO, HUIZ, AAME, FGF, OXBR, CNFR, and TIRX

Should you be buying Health In Tech stock or one of its competitors? The main competitors of Health In Tech include Roadzen (RDZN), ICC (ICCH), NeueHealth (NEUE), Zhibao Technology (ZBAO), Huize (HUIZ), Atlantic American (AAME), Fundamental Global (FGF), Oxbridge Re (OXBR), Conifer (CNFR), and Tian Ruixiang (TIRX). These companies are all part of the "insurance" industry.

Health In Tech vs.

Health In Tech (NASDAQ:HIT) and Roadzen (NASDAQ:RDZN) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.

Roadzen received 3 more outperform votes than Health In Tech when rated by MarketBeat users.

CompanyUnderperformOutperform
Health In TechN/AN/A
RoadzenOutperform Votes
3
100.00%
Underperform Votes
No Votes

Roadzen has a consensus target price of $5.00, indicating a potential upside of 352.49%. Given Roadzen's stronger consensus rating and higher probable upside, analysts plainly believe Roadzen is more favorable than Health In Tech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health In Tech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Roadzen
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

24.7% of Roadzen shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Health In Tech had 5 more articles in the media than Roadzen. MarketBeat recorded 7 mentions for Health In Tech and 2 mentions for Roadzen. Roadzen's average media sentiment score of 1.31 beat Health In Tech's score of 0.60 indicating that Roadzen is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Health In Tech
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Roadzen
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Health In Tech has higher earnings, but lower revenue than Roadzen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health In Tech$19.49M1.85N/AN/AN/A
Roadzen$42.89M1.91-$99.67M-$1.51-0.73

Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -248.79%.

Company Net Margins Return on Equity Return on Assets
Health In TechN/A N/A N/A
Roadzen -248.79%N/A -269.99%

Summary

Roadzen beats Health In Tech on 8 of the 11 factors compared between the two stocks.

Remove Ads
Get Health In Tech News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIT vs. The Competition

MetricHealth In TechInsurance Agents, Brokers & Service IndustryFinance SectorNASDAQ Exchange
Market Cap$36.04M$35.61M$11.28B$7.72B
Dividend YieldN/AN/A5.39%4.03%
P/E RatioN/AN/A22.6118.60
Price / Sales1.851.8325.5089.09
Price / CashN/AN/A17.6234.64
Price / BookN/AN/A2.614.10
Net IncomeN/AN/A$1.04B$247.10M
7 Day Performance3.11%0.95%-1.04%-4.02%
1 Month Performance-90.64%-45.38%495.21%-6.40%
1 Year PerformanceN/AN/A536.12%-2.12%

Health In Tech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIT
Health In Tech
N/A$0.66
-3.0%
N/AN/A$36.04M$19.49M0.0079Gap Down
RDZN
Roadzen
2.1856 of 5 stars
$1.14
+1.8%
$5.00
+338.6%
-85.1%$84.58M$42.89M-0.75324Positive News
Gap Up
ICCH
ICC
1.5918 of 5 stars
$23.49
flat
N/AN/A$73.74M$93.57M10.5890Positive News
NEUE
NeueHealth
0.9023 of 5 stars
$5.49
+4.1%
$7.00
+27.6%
+5.4%$45.45M$996.89M-0.111,252Short Interest ↑
Gap Up
High Trading Volume
ZBAO
Zhibao Technology
N/A$1.22
-3.2%
N/AN/A$38.46M$183.67M0.00148Positive News
HUIZ
Huize
1.3019 of 5 stars
$3.20
-0.3%
N/A-82.1%$31.83M$1.20B35.561,113Earnings Report
Short Interest ↓
AAME
Atlantic American
1.5715 of 5 stars
$1.37
-4.9%
N/A-38.6%$27.95M$185.93M-3.91140Earnings Report
Upcoming Earnings
Dividend Announcement
Gap Down
High Trading Volume
FGF
Fundamental Global
1.1461 of 5 stars
$18.12
-2.1%
N/A-46.6%$22.92M$45.61M13.839
OXBR
Oxbridge Re
0.7718 of 5 stars
$2.17
-7.3%
N/A+90.6%$14.62M$-1,781,000.00-2.583Earnings Report
Analyst Forecast
CNFR
Conifer
1.7682 of 5 stars
$0.71
-2.8%
N/A-41.8%$8.68M$74.82M0.29150Earnings Report
Upcoming Earnings
Gap Down
TIRX
Tian Ruixiang
1.6622 of 5 stars
$1.52
+10.1%
N/A-40.9%$1.10M$3.22M0.0050Short Interest ↓
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:HIT) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners